CLINICAL_TRIALS trial_result · 2023-10-04

Clinical Trial Update: Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

Phase 2 study evaluating the mode of action of QBW251 in chronic obstructive pulmonary disease has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-10-04